AEGON Files Routine 6-K on March 25, 2026; No New Material Info
Ticker: AEG · Form: 6-K · Filed: Mar 25, 2026 · CIK: 0000769218
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, foreign-issuer, administrative
TL;DR
**AEGON's 6-K is a standard procedural filing, nothing new to see here.**
AI Summary
AEGON LTD. filed a 6-K on March 25, 2026, indicating a routine report for a foreign issuer. This filing, with accession number 0001171843-26-001894, provides basic company information like its business address at World Trade Center Schiphol, Netherlands, and its CIK 0000769218. For investors, this specific 6-K filing itself doesn't contain new material financial or operational news, meaning there's no immediate impact on the stock price from this particular document.
Why It Matters
This filing is a standard report for foreign companies and doesn't contain any new financial or operational disclosures, so it's unlikely to move the stock.
Risk Assessment
Risk Level: low — This 6-K is a routine administrative filing and does not disclose any new risks or material information.
Analyst Insight
Investors should recognize this 6-K as a standard procedural filing and look for other, more substantive filings or company announcements for material news regarding AEGON LTD.
Key Numbers
- 2026-03-25 — Filing Date (the date the 6-K was filed)
- 35218 — Size of 6-K document (the size in bytes of the f6k_032526.htm document)
Key Players & Entities
- AEGON LTD. (company) — the filer of the 6-K
- 0000769218 (company) — AEGON LTD.'s CIK number
- 0001171843-26-001894 (dollar_amount) — the SEC Accession No. for this filing
- World Trade Center Schiphol (company) — AEGON LTD.'s business and mailing address
Forward-Looking Statements
- AEGON LTD.'s stock price will remain unaffected by this specific 6-K filing. (AEGON LTD.) — high confidence, target: 2026-03-26
FAQ
What is the purpose of a 6-K filing for AEGON LTD.?
A 6-K filing is a 'Report of foreign issuer' under Rules 13a-16 and 15d-16, used by foreign private issuers like AEGON LTD. to report information that is material to investors and made public in their home country or filed with a foreign stock exchange.
When was this specific 6-K filing by AEGON LTD. accepted by the SEC?
This 6-K filing by AEGON LTD. was accepted by the SEC on 2026-03-25 at 09:56:41.
What is the CIK number for AEGON LTD. as listed in this filing?
The CIK number for AEGON LTD. is 0000769218, as stated in the filing.
Where is AEGON LTD.'s business address located according to this 6-K?
AEGON LTD.'s business address is listed as WORLD TRADE CENTER SCHIPHOL, SCHIPHOL BOULEVARD 223, SCHIPHOL, Netherlands 1118 BH.
Does this 6-K filing contain new financial or operational news for investors?
Based on the provided text, this 6-K filing appears to be a routine administrative report and does not contain any new material financial or operational news for investors.
Filing Stats: 2,423 words · 10 min read · ~8 pages · Grade level 14.6 · Accepted 2026-03-25 09:56:41
Filing Documents
- f6k_032526.htm (6-K) — 34KB
- 0001171843-26-001894.txt ( ) — 36KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Aegon Ltd (Registrant) Date: March 25, 2026 /s/ J.O. van Klinken J.O. van Klinken Executive Vice President and General Counsel Aegon nominates Marco Keim to succeed Lard Friese on the Supervisory Board of a.s.r. Schiphol, March 25, 2026 - Aegon has nominated Marco Keim, CEO of Aegon's International business and a member of the Executive Committee, to succeed Aegon CEO, Lard Friese, as a non-independent member of the Supervisory Board of Dutch insurer, a.s.r., in which Aegon holds a strategic stake of approximately 24%. The nomination follows Aegon's announcement on December 10, 2025, that Mr. Friese would step down as a non-independent member of a.s.r.'s Supervisory Board to focus on the relocation of Aegon's head office and legal seat to the US. The proposal to appoint Mr. Keim will be voted on at a.s.r.'s Annual General Meeting (AGM) on May 20, 2026, as announced by a.s.r. today. Subject to shareholder approval, Mr. Keim will take up his position on a.s.r.'s Supervisory Board as of the closing of the AGM until July 4, 2028, in accordance with the Relationship Agreement between Aegon and a.s.r. Mr. Keim is well placed to represent Aegon's shareholding on the Supervisory Board of a.s.r. He brings extensive senior leadership experience in the financial services sector, combined with a strong understanding of the Dutch insurance market. Mr. Keim joined Aegon in 2008 as CEO of Aegon the Netherlands. Before that, he was CEO of Zwitserleven. He has also held senior leadership roles in marketing within the insurance sector, as well as in other industries. In addition, Mr. Keim has held various supervisory roles. Contacts Media relations Investor relations Carolien van der Giessen Yves Cormier +31 611 953 367 +44 782 337 1511 carolien.vandergiessen@aegon.co
forward-looking statements, which merely reflect the company's expectations at the
forward-looking statements, which merely reflect the company's expectations at the time of writing. Actual results may differ materially and adversely from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include, but are not limited to, the following: Changes in general economic and/or governmental conditions, particularly in Bermuda, the United States, the United Kingdom and, in relation to Aegon's shareholding in ASR Nederland N.V., and Aegon's asset management business, the Netherlands. Civil unrest, (geo-) political tensions, military action or other instability in countries or geographic regions that affect our operations or that affect global markets. Changes in the performance of financial markets, including emerging markets, such as: The frequency and severity of defaults by issuers in Aegon's fixed income investment portfolios. The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds. The effects of declining creditworthiness of certain public sector securities and the resulting decline in the value of government exposure that Aegon holds. The impact from volatility in credit, equity, and interest rates. Changes in the performance of Aegon's investment portfolio and a decline in the ratings of Aegon's counterparties. The effect of tariffs and potential trade wars on trading markets and on economic growth, both globally and in the markets where Aegon operates. The lowering of one or more of Aegon's debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegon's ability to raise capital and on its liquidity and financial condition. The lowering of one or more insurer financial strength ratings of Aegon's insurance subsidiaries and the adverse impact such action may have on the written premium, po